---
layout: post
title: "葛兰素史克(GSK.US)-Vir(VIR.US)新冠疗法对Omicron亚型有效"
date: 2022-02-10 15:42:14 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/106.GSK" data-code="GSK|106|7" data-code2="GSK|106|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=106.GSK&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 GSK_0" data-code="K GSK|106|7" data-code2="K GSK|106|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/155.GSK" data-code="GSK|155|_UKS" data-code2="GSK|155|1|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=155.GSK&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 GSK_0" data-code="K GSK|155|_UKS" data-code2="K GSK|155|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/105.VIR" data-code="VIR|105|7" data-code2="VIR|105|1|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.VIR&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 VIR_0" data-code="K VIR|105|7" data-code2="K VIR|105|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>Vir Biotechnology(VIR.US)周四援引临床前数据称，葛兰素史克(GSK.US)和Vir Biotechnology开发的基于抗体的新冠疗法可以有效对抗BA.2型Omicron冠状病毒变种。<br /></p><p>单克隆抗体疗法sotrovimab目前在美国被批准紧急使用。Vir表示，双方公司正在与全球监管机构分享最新的数据。</p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202102272632434>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)